Amyloid deposition and cognition in older adults: the effects of premorbid intellect.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Archives of Clinical Neuropsychology

• Publication date

  2013-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/arclin/act047PMID 23817438PMCID PMC3807831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Implementation and Validation of an Adaptive Template Registration Method for 18F-Flutemetamol Imaging Data

  2013cited by this paper
• &bgr;-Amyloid burden in healthy aging: Regional distribution and cognitive consequences

  2012influential reference
• Combination of Biomarkers: PET [18F]Flutemetamol Imaging and Structural MRI in Dementia and Mild Cognitive Impairment

  2012influential reference
• Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.

  2012cited by this paper
• Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition

  2011cited by this paper
• Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.

  2011cited by this paper
• Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology.

  2011cited by this paper
• A Life Course Model of Cognitive Activities, Socioeconomic Status, Education, Reading Ability, and Cognition

  2011cited by this paper
• Alzheimer's disease: strategies for disease modification

  2010cited by this paper
• Malignant astrocytomas: a system disease.

  2010cited by this paper
• 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

  2010influential reference
• Predicting Premorbid Memory Functioning in Older Adults

  2010influential reference
• Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.

  2010influential reference
• Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

  2009cited by this paper
• Cognition, Reserve, and Amyloid Deposition in Normal Aging

  2009cited by this paper
• Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease

  2009cited by this paper
• Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake.

  2008cited by this paper
• Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

  2007influential reference
• β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

  2007influential reference
• Cognitive Reserve and Alzheimer Disease

  2006cited by this paper
• Cognitive reserve and Alzheimer disease.

  2006cited by this paper
• Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

  2004cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.

  1998cited by this paper

• Change on the Repeatable Battery for the Assessment of Neuropsychological Status and its relationship to brain amyloid

  2023cites this paper
• Recall and recognition subtests of the repeatable battery for the assessment of neuropsychological status and their relationship to biomarkers of Alzheimer’s disease

  2022cites this paper
• Repeatable battery for the assessment of neuropsychological status and its relationship to biomarkers of Alzheimer’s disease

  2021cites this paper
• Predicting biomarkers in intact older adults and those with amnestic Mild Cognitive Impairment, and mild Alzheimer’s Disease using the Repeatable Battery for the Assessment of Neuropsychological Status

  2021influential citation
• Description of the Method for Evaluating Digital Endpoints in Alzheimer Disease Study: Protocol for an Exploratory, Cross-sectional Study

  2021cites this paper
• Consideration of different scoring approaches for a verbal incidental learning measure from the WAIS-IV using hippocampal volumes

  2021cites this paper
• Relationship between a novel learning slope metric and Alzheimer’s disease biomarkers

  2021cites this paper
• Improving Prediction of Amyloid Deposition in Mild Cognitive Impairment With a Timed Motor Task

  2021cites this paper
• Examining the Relationship between a Verbal Incidental Learning Measure from the WAIS-IV and Neuroimaging Biomarkers for Alzheimer’s Pathology

  2020cites this paper
• Validation of one-week reliable change methods in cognitively intact community-dwelling older adults

  2020cites this paper
• Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET

  2020cites this paper
• Long-term Changes in 18F-Flutemetamol Uptake in Nondemented Older Adults

  2019cites this paper
• External validation of change formulae in neuropsychology with neuroimaging biomarkers: A methodological recommendation and preliminary clinical data

  2018cites this paper
• SPECT and PET imaging in Alzheimer’s disease

  2018cites this paper
• Amyloid Positivity Using [18F]Flutemetamol-PET and Cognitive Deficits in Nondemented Community-Dwelling Older Adults

  2017cites this paper
• Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility

  2017cites this paper
• Relationship between 18F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults

  2017cites this paper
• Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project

  2017cites this paper
• Short-Term Practice Effects and Amyloid Deposition: Providing Information Above and Beyond Baseline Cognition.

  2017cites this paper
• Imaging β-amyloid using [18F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis

  2016cites this paper
• The interactive effects of age, education, and BMI on cognitive functioning

  2016cites this paper
• Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageing.

  2015cites this paper
• Amyloid imaging in Alzheimer's disease: A literature review

  2014cites this paper
• Task-Induced Brain Activity Patterns in Type 2 Diabetes: A Potential Biomarker for Cognitive Decline

  2014influential citation